# Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis

> **NCT01900431** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 58 (actual)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Sarilumab
- **DRUG:** Prednisone
- **DRUG:** Methotrexate
- **DRUG:** Folic/folinic acid
- **OTHER:** Placebo (for Sarilumab)

## Key facts

- **NCT ID:** NCT01900431
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-07
- **Final completion:** 2016-04
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01900431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01900431, "Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01900431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*